Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Granules India Ltd

NSE: GRANULES · BSE: 532482 · Pharmaceuticals & Biotechnology · 41 announcements

Granules India Ltd news stories on ALFA NewsRead the news →
Share price
₹836.40
Market cap
₹20,726 Cr
Revenue (annual)
₹5,366 Cr
Net profit (annual)
₹595.0 Cr
P/E (TTM)
31.3×Sector 47.4×
Promoter holding
37.39%-0.63% QoQ
FII holding
20.29%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14:14 IST BSE
Business Update

Granules India Business Update

Granules India Ltd submitted a Monitoring Agency report for the quarter ended June 30, 2026. The report tracks proceeds from a Preferential Issue.

Value
₹1,762 Cr
12:32 IST BSE
Business Update

Granules India Business Update

Granules India Limited released its Business Responsibility & Sustainability Report for FY 2025-26. The report highlights achievements in ESG, climate action, and workplace safety certifications.

11:44 IST NSE
Business Update

Granules India Business Update

Granules India's US subsidiary received a USFDA EIR with VAI classification for its Chantilly facility. The report concludes a March 2026 inspection involving four observations.

15:19 IST NSE
Business Update

Granules India Business Update

Granules India's US subsidiary, GPI, completed a routine US FDA cGMP audit at its Chantilly, Virginia site with four procedural observations. The inspection, conducted from March 30 to April 3, 2026, reported no data integrity issues. The company committed to addressing the observations within stipulated timelines to maintain regulatory compliance.

Execution
March 30 to April 3, 2026